Press Releases
Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference
Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update
Ceapro Inc. to Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids
Ceapro Inc. Announces Publication of Results for PGX-Processed Alginates in the Journal of CO2 Utilization
Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors
Ceapro Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Ceapro Signs Exclusive Long-Term Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise
Ceapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical Industry
Ceapro Inc. to Present at the Virtual Investor 2022 Top Picks Conference
